Camille L. Bedrosian, EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 3,314 shares at $66.30 ($220K) on 2022-01-30, disclosed to the SEC on 2022-02-01.
Open-market sale of $220k RARE by EVP and Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.30 | 1,657 | $110K | 50.0% |
| 2 | $66.30 | 1,657 | $110K | 50.0% |
| Total | $66.30 avg | 3,314 | $220K | 100% |
| Filing → |
| AMLX | SELL | 2025-12-03 | $94K | — | Filing → |
| AMLX | SELL | 2025-10-02 | $351K | — | Filing → |
| AMLX | SELL | 2025-04-02 | $43K | — | Filing → |